Study To Evaluate Safety, Pharmacokinetics, Pharmacodynamics, And Preliminary Anti-Tumor Activity Of RO7122290 In Combination With Cibisatamab With Obinutuzumab Pre-Treatment
Clinical trial NCT04826003 · COMPLETED
Trial details
- NCT number
- NCT04826003
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-14
- Primary completion
- 2024-11-11
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.